John Connelly

1.7k total citations
36 papers, 1.1k citations indexed

About

John Connelly is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, John Connelly has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Oncology. Recurrent topics in John Connelly's work include European history and politics (4 papers), Hemoglobinopathies and Related Disorders (4 papers) and DNA Repair Mechanisms (3 papers). John Connelly is often cited by papers focused on European history and politics (4 papers), Hemoglobinopathies and Related Disorders (4 papers) and DNA Repair Mechanisms (3 papers). John Connelly collaborates with scholars based in United States, Canada and Germany. John Connelly's co-authors include Michael Spino, Fernando Tricta, Anne Monks, Antonio Martín‐Bastida, David T. Dexter, Roberta J. Ward, Maneesh C. Patel, Robert R. Crichton, David Sharp and Rexford D. Newbould and has published in prestigious journals such as Blood, PLoS ONE and Circulation Research.

In The Last Decade

John Connelly

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Connelly United States	16	521	216	167	134	130	36	1.1k
Darcy Franicola United States	18	460 0.9×	116 0.5×	230 1.4×	56 0.4×	71 0.5×	65	895
Arineh Khechaduri United States	14	772 1.5×	287 1.3×	225 1.3×	178 1.3×	116 0.9×	18	1.6k
Xiaofei Qi China	14	493 0.9×	106 0.5×	42 0.3×	114 0.9×	34 0.3×	61	850
Steven R. Presnell United States	19	792 1.5×	226 1.0×	45 0.3×	67 0.5×	117 0.9×	29	1.6k
Robert A. Galemmo United States	19	494 0.9×	158 0.7×	33 0.2×	143 1.1×	50 0.4×	46	1.0k
Takao Fujisawa Japan	13	861 1.7×	119 0.6×	31 0.2×	167 1.2×	75 0.6×	27	1.1k
Petra Obexer Austria	24	1.2k 2.3×	396 1.8×	124 0.7×	90 0.7×	29 0.2×	43	1.8k
Juris J. Liepnieks United States	29	2.2k 4.2×	340 1.6×	122 0.7×	60 0.4×	354 2.7×	65	2.5k
Vijaya L. Damaraju Canada	20	483 0.9×	476 2.2×	70 0.4×	146 1.1×	28 0.2×	51	1.4k
Gary E. Schiltz United States	18	910 1.7×	306 1.4×	135 0.8×	72 0.5×	22 0.2×	52	1.5k

Countries citing papers authored by John Connelly

Since Specialization

Citations

This map shows the geographic impact of John Connelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Connelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Connelly more than expected).

Fields of papers citing papers by John Connelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Connelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Connelly. The network helps show where John Connelly may publish in the future.

Co-authorship network of co-authors of John Connelly

This figure shows the co-authorship network connecting the top 25 collaborators of John Connelly. A scholar is included among the top collaborators of John Connelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Connelly. John Connelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lenz, Joan Sesing, Philip Burnham, Alfred Andama, et al.. (2022). Metagenomic DNA sequencing to quantify Mycobacterium tuberculosis DNA and diagnose tuberculosis. Scientific Reports. 12(1). 16972–16972. 4 indexed citations

Byrnes, Samantha A., Ryan Gallagher, Crissa Bennett, et al.. (2021). Multiplexed and Extraction-Free Amplification for Simplified SARS-CoV-2 RT-PCR Tests. Analytical Chemistry. 93(9). 4160–4165. 47 indexed citations

Cate, David M., Joshua D. Bishop, Helen V. Hsieh, et al.. (2021). Antibody Screening Results for Anti-Nucleocapsid Antibodies Toward the Development of a Lateral Flow Assay to Detect SARS-CoV-2 Nucleocapsid Protein. ACS Omega. 6(39). 25116–25123. 19 indexed citations

Weyers, Jill J., Xiuling Qi, Jennifer Barry, et al.. (2020). Action of iron chelator on intramyocardial hemorrhage and cardiac remodeling following acute myocardial infarction. Basic Research in Cardiology. 115(3). 24–24. 32 indexed citations

Krushkal, Julia, Thomas Silvers, William C. Reinhold, et al.. (2020). Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets. Clinical Epigenetics. 12(1). 93–93. 50 indexed citations

Evans, David M., Jianwen Fang, Thomas Silvers, et al.. (2019). Exposure time versus cytotoxicity for anticancer agents. Cancer Chemotherapy and Pharmacology. 84(2). 359–371. 22 indexed citations

Barizuddin, Syed, Cherian J. Mathai, Alexey Ball, et al.. (2019). Ultrasensitive detection of lipoarabinomannan with plasmonic grating biosensors in clinical samples of HIV negative patients with tuberculosis. PLoS ONE. 14(3). e0214161–e0214161. 16 indexed citations

Martín‐Bastida, Antonio, Roberta J. Ward, Rexford D. Newbould, et al.. (2017). Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease. Scientific Reports. 7(1). 1398–1398. 295 indexed citations

Saxena, Deepti, Michael Spino, Fernando Tricta, et al.. (2016). Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial. PLoS ONE. 11(5). e0154842–e0154842. 31 indexed citations

10.

Polley, Eric C., Mark W. Kunkel, David M. Evans, et al.. (2016). Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression. JNCI Journal of the National Cancer Institute. 108(10). djw122–djw122. 106 indexed citations

11.

Bellanti, Francesco, Giancarlo Vecchio, Maria Caterina Putti, et al.. (2016). Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years. British Journal of Clinical Pharmacology. 83(3). 593–602. 12 indexed citations

12.

Teicher, Beverly A., Eric C. Polley, Mark W. Kunkel, et al.. (2015). Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression. Molecular Cancer Therapeutics. 14(11). 2452–2462. 55 indexed citations

13.

Hanauske‐Abel, Hartmut M., Deepti Saxena, Paul Palumbo, et al.. (2013). Drug-Induced Reactivation of Apoptosis Abrogates HIV-1 Infection. PLoS ONE. 8(9). e74414–e74414. 33 indexed citations

14.

Bentley, Anthony, Samantha Gillard, Michael Spino, John Connelly, & Fernando Tricta. (2013). Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective. PharmacoEconomics. 31(9). 807–822. 16 indexed citations

15.

Lee, Daniel Sang‐Hoon & John Connelly. (2010). Global Aquaculture Alliance on Best Aquaculture Practices: An Industry Prepares For Sustainable Growth. Sustainable development law & policy. 7(1). 20. 4 indexed citations

16.

Jobson, Andrew G., G.T. Lountos, Philip L. Lorenzi, et al.. (2009). Cellular Inhibition of Checkpoint Kinase 2 (Chk2) and Potentiation of Camptothecins and Radiation by the Novel Chk2 Inhibitor PV1019 [7-Nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]. Journal of Pharmacology and Experimental Therapeutics. 331(3). 816–826. 81 indexed citations

17.

Wallqvist, Anders, John Connelly, Edward A. Sausville, David G. Covell, & Anne Monks. (2005). Differential Gene Expression as a Potential Classifier of 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole-Sensitive and -Insensitive Cell Lines. Molecular Pharmacology. 69(3). 737–748. 2 indexed citations

18.

Connelly, John, et al.. (2003). Zwischen Autonomie und Anpassung : Universitäten in den Diktaturen des 20. Jahrhunderts. Bayerische Staatsbibliothek.

19.

Monks, Anne, Erik Harris, Curtis Hose, John Connelly, & Edward A. Sausville. (2003). Genotoxic Profiling of MCF-7 Breast Cancer Cell Line Elucidates Gene Expression Modifications Underlying Toxicity of the Anticancer Drug 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole. Molecular Pharmacology. 63(3). 766–772. 47 indexed citations

20.

Connelly, John, et al.. (1990). Lead Concentrations in Golden and Bald Eagles. Digital Commons - University of South Florida (University of South Florida). 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact